PPARGC1A and Cognitive impairment: <b>Results:</b> <i>P.g</i> administration in WT mice induced cognitive deficits, hippocampal neurodegeneration, p-Tau accumulation, and neuroinflammation, accompanied by dysregulated mitochondrial genes (NOX4, PPAR-α, and PGC-1α) and ferroptosis activation.